Bayer Recalls Two Lots of Kogenate 2000 Iu Vials in U.S.: FDA

July 19, 2019, 9:27 PM UTC

Bayer is voluntarily recalling two lots of Kogenate FS antihemophilic factor 2000 IU vials in U.S. to the patient level, FDA said in a statement.

  • Certain vials from these two lots that were labeled as Kogenate FS actually contain the FVIII hemophilia A treatment, Jivi antihemophilic factor PEGylated-aucl 3000 IU, it said

©2019 Bloomberg L.P. All rights reserved. Used with permission

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.